全球系统性红斑狼疮市场 - 行业趋势和 2029 年预测

市场分析与洞察全球系统性红斑狼疮市场

系统性红斑狼疮市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 7.55%，到 2029 年可能达到 12.7 亿美元。

系统性红斑狼疮 (SLE) 是一种自身免疫性疾病。在这种情况下，人体的免疫系统会错误地破坏健康组织。皮肤、关节、肾脏、大脑和其他器官都可能受到影响。女性患 SLE 的几率比男性高出十倍。它可以影响任何年龄的任何人。然而，15 至 44 岁的年轻女性最容易受到影响。这种疾病的体征和症状包括胸痛、疲劳、淋巴结肿大、发烧、全身不适、不安、脱发、体重减轻、口腔溃疡、对阳光敏感和皮疹等。

系统性红斑狼疮在世界范围内的患病率上升将成为系统性红斑狼疮市场扩张的主要驱动力。此外，老年人口的增加和医疗支出的增加也是系统性红斑狼疮市场扩张的因素。生活方式的改变和对炎症性自身免疫性疾病和疾病诊断治疗的认识的提高等其他因素也将对市场增长率产生积极影响。此外，医疗技术的进步、政府资金的增加和可支配收入水平的提高也是系统性红斑狼疮市场增长率上升的因素。

Moreover, the rise in the research and development activities, launch of effective therapies and emerging new markets will provide beneficial opportunities for the systemic lupus erythematosus market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate of market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of market. Additionally, complications involved with disease will hinder the market growth. Less awareness will further challenge the market in the forecast period mentioned above.

This systemic lupus erythematosus market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the systemic lupus erythematosus market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Systemic Lupus Erythematosus Market Scope and Market Size

The systemic lupus erythematosus market is segmented on the basis of treatment type, diagnosis, dosage form, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment type, the systemic lupus erythematosus market is segmented into antimalarial drugs, non-steroidal anti-inflammatory drugs, cytotoxic and immunosuppressive drugs, disease-modifying anti-rheumatic drugs, monoclonal antibodies, anticoagulants, biologics, others.
• On the basis of diagnosis, the systemic lupus erythematosus market is segmented into blood tests, urinalysis, and chest x-ray. Blood tests are further sub-segmented into antibody tests and a complete blood count.
• On the basis of dosage form, the systemic lupus erythematosus market is segmented into tablet, capsule, injection and others.
• Based on route of administration, the systemic lupus erythematosus market is segmented into oral, intravenous, subcutaneous.
• Based on symptoms, the systemic lupus erythematosus market is segmented into chest pain, fatigue, swollen lymph nodes, fever, general discomfort, uneasiness, hair loss, weight loss, mouth sores, sensitivity to sunlight, skin rash and others.
• On the basis of end-users, the systemic lupus erythematosus market is segmented into clinic, hospital and others.
• The systemic lupus erythematosus market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Systemic Lupus Erythematosus Market Country Level Analysis

Systemic lupus erythematosus market is analyzed and market size information is provided by the country, treatment type, diagnosis, dosage form, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the systemic lupus erythematosus market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the systemic lupus erythematosus market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increase in the adoption of advanced technologies, changing lifestyle and growing population in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Systemic lupus erythematosus market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

竞争格局和全球系统性红斑狼疮市场份额分析

系统性红斑狼疮市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对系统性红斑狼疮市场研究的关注有关。

系统性红斑狼疮市场的一些主要参与者包括百时美施贵宝公司、默克公司、ImmuPharma PLC、葛兰素史克公司、罗氏公司、Anthera Pharmaceuticals、Inc.、礼来公司、辉瑞公司、默克公司、Lycera、Mylan NV、赛诺菲、Aurinia Pharmaceuticals Inc.、Sandoz International GmbH、诺华公司、拜耳公司、Zydus Cadila、Corbus Pharmaceuticals Holdings Inc.、Trinity Biotech、EUROIMMUN AG、bioMérieux SA、Quest 和 Bio-Rad Laboratories Inc. 等。

SKU-26334